| Nov-18-20 10:16AM |
Tiziana Life Sciences PLC ("Tiziana" or the "Company") - PDMR DealingGlobeNewswire |
| Nov-11-20 02:00AM |
Tiziana Life Sciences announces collaboration with Parexel Biotech to conduct phase 1b/2 clinical trial in patients with Crohn’s DiseaseGlobeNewswire |
| Nov-02-20 03:31AM |
Tiziana Kicks Off Covid-19 Treatment Trial In Brazil; Stock Up 250% YTDSmarterAnalyst |
| 02:00AM |
Tiziana Announces Initiation of Clinical Trial with Covid-19 Patients in Brazil with Nasally Administered Foralumab, a Fully Human Anti-CD3 Monoclonal AntibodyGlobeNewswire |
| Oct-27-20 12:00PM |
Tiziana Life Sciences Announces Timetable of Demerger of Accustem (for holders of Tiziana ADRs)GlobeNewswire |
| Oct-22-20 07:28AM |
Tiziana Life's (TLSA) Shares March Higher, Can It Continue?Zacks |
| Oct-02-20 07:00AM |
Tiziana Life Sciences Plc (the "Company") - Result of General MeetingGlobeNewswire |
| Sep-25-20 02:00AM |
Tiziana Life Sciences Interview to Air on Bloomberg International on The RedChip Money ReportGlobeNewswire |
| Sep-21-20 09:51AM |
Tiziana Life Sciences plc: Publication of Research NoteGlobeNewswire |
| Sep-17-20 02:00AM |
Tiziana Life Sciences plc to Conduct a Clinical Study with Nasally Administered Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, for Treatment of COVID-19 Patients in BrazilGlobeNewswire |
| Sep-16-20 10:10AM |
Tiziana Life Sciences PLC (LON:TILS) Insiders Increased Their HoldingsSimply Wall St. |
| 06:00AM |
Tiziana Life Sciences Announces Planned Spin Out of StemPrintER into a New Publicly Listed Company, Accustem SciencesGlobeNewswire |
| Sep-16-20 02:00AM |
Tiziana Life Sciences Plc ("Tiziana" or the "Company") - Demerger of StemPrintER and Distribution in SpecieGlobeNewswire |
| Aug-28-20 05:30AM |
Tiziana Life Sciences Clarifies Reason for Filing an Amended ADS Registration StatementGlobeNewswire |
| Aug-27-20 02:00AM |
Tiziana Life Sciences CEO Updates Shareholders on its Patent Portfolio, Clinical Pipeline, and Strategy in an Exclusive InterviewGlobeNewswire |
| Aug-24-20 08:42AM |
Tiziana Wins Patent for Potential Covid-19 TreatmentTheStreet.com |
| 03:14AM |
Tiziana Wins Patent Approval For TZLS-501 Potential Covid-19 TreatmentSmarterAnalyst |
| Aug-24-20 02:00AM |
Tiziana Granted a Patent on Methods and Use of Anti-IL-6/IL-6 receptor Monoclonal Antibodies as Prophylactic and Therapeutic Interventions for COVID-19 and other pulmonary diseasesGlobeNewswire |
| Aug-21-20 02:00AM |
Tiziana Granted a Patent on the Use of Milciclib in Combination with Tyrosine Kinase Inhibitors for Treatment of Hepatocellular Carcinoma and other CancersGlobeNewswire |
| Aug-20-20 02:00AM |
Tiziana is Pleased to Retain Dr. Napoleone Ferrara to Serve on Its Scientific Advisory Board for an Additional Three-Year TermGlobeNewswire |
| Aug-18-20 06:08AM |
Tiziana Spikes 25% In Pre-Market On Patent Win For ForalumabSmarterAnalyst |
| 02:00AM |
Tiziana Granted a Patent on Methods and Use of Anti-CD3 Monoclonal Antibodies for Treatment of Crohn’s DiseaseGlobeNewswire |
| Aug-11-20 04:00AM |
Tiziana Life Sciences to Present at BTIG’s Virtual Biotechnology ConferenceGlobeNewswire |
| Aug-06-20 03:57AM |
LD Micro:- Announces Preliminary List of Presenters for the LD 500.ACCESSWIRE |
| Aug-05-20 11:00AM |
Tiziana Life Sciences plc Announces Closing of $57.25 Million OfferingGlobeNewswire |
| Aug-04-20 02:00AM |
Tiziana Life Sciences Announces an Expedited Clinical Development Plan for Its Anti-Interleukin-6-Receptor, a Fully Human Monoclonal Antibody, for the Treatment of COVID-19 PatientsGlobeNewswire |
| Aug-03-20 02:00AM |
Tiziana Announces Pricing of U.S. Follow-On Offering of ADSs Raising $57.25 millionGlobeNewswire |
| Jul-31-20 12:05PM |
Why Tiziana Life Sciences' Stock Is Trading Higher TodayBenzinga |
| 12:00PM |
Tiziana Life Sciences plc: Total Voting RightsGlobeNewswire |
| Jul-31-20 02:00AM |
Tiziana Life Sciences plc: Tiziana Announces Submission of a Patent Application for Nasal Administration of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, for Treatment of COVID-19 PatientsGlobeNewswire |
| Jul-30-20 11:31AM |
Tiziana Life Sciences plc: Early notification of proposed admission to the Official List and cancellation of trading on AIMGlobeNewswire |
| 02:00AM |
Tiziana Life Sciences to Participate in Investor Webinar to Provide Corporate Updates and Q&A Session on July 30, 2020GlobeNewswire |
| Jul-24-20 02:00AM |
Exercise of Warrants and Issue of Equity and Total Voting RightsGlobeNewswire |
| Jul-20-20 10:17AM |
Tiziana Life Sciences plc ("Tiziana" or the "Company") Director AppointmentGlobeNewswire |
| Jul-16-20 07:23AM |
Results of Annual General MeetingGlobeNewswire |
| 02:00AM |
Tiziana Announces Submission of Patent Application on Use of Foralumab, the Only Fully Human Anti-CD3 Monoclonal Antibody, to Enhance Success of CAR-T TherapyGlobeNewswire |
| Jul-15-20 06:34AM |
Tesla Hit a New High. No, It Was TLSA. Confused?Barrons.com |
| 04:47AM |
Tesla Ticker Confusion May Be Aiding Biotech Stock’s RallyBloomberg |
| Jul-15-20 11:56AM |
Tiziana Life Sciences plc Change to ADS Ratio - UpdatedGlobeNewswire |
| 08:28AM |
Tiziana Life Sciences plc Change to ADS RatioGlobeNewswire |
| Jul-14-20 10:41AM |
Tiziana Life Sciences PLC (TLSA) Shares March Higher, Can It Continue?Zacks |
| Jul-10-20 01:41AM |
Tiziana Life Sciences Interview to Air on Bloomberg International on the RedChip Money ReportGlobeNewswire |
| Jun-30-20 09:35AM |
Company News for Jun 30, 2020Zacks |
| Jun-29-20 03:12AM |
Tiziana Life Sciences Announces Agreement with STC Biologics for GMP Manufacturing of an anti-Interleukin-6-Receptor Monoclonal Antibody for Clinical Studies in Patients with COVID-19GlobeNewswire |
| Jun-19-20 07:41AM |
The Daily Biotech Pulse: Tiziana Snags A Patent Win, Decision Day For Nabriva And Evoke, IPOsBenzinga |
| 02:00AM |
Tiziana Granted First-Ever Patent on a Transformational Technology for Oral Delivery of all Anti-CD3 Monoclonal Antibodies for Treatment of Human DiseasesGlobeNewswire |
| Jun-18-20 01:50AM |
Tiziana Life Sciences PLC Directorate ChangeGlobeNewswire |
| Jun-04-20 02:00AM |
Tiziana Life Sciences announces that its Scientific Advisory Board Chairman Dr. Howard Weiner received NIH grant to investigate Nasal Anti-CD3 for the treatment of Alzheimer’s diseaseGlobeNewswire |
| May-29-20 02:00AM |
Tiziana Life Sciences announces presentation of StemPrintER, a superior prognostic test as compared to Oncotype DX to predict breast cancerGlobeNewswire |
| May-22-20 02:00AM |
Tiziana Lifesciences Announces Intention to Demerge Its StemPrintER Genomics-Based Personalized Medicine Business as a Separate Listed CompanyGlobeNewswire |
News
Options
Financials
Holders
Transactions
Discussions
investlink
·
November 25, 2020
DueDiligenceSmart
·
November 18, 2020
Peter
·
November 12, 2020
Brendan
·
November 11, 2020
Gilreath
·
November 09, 2020
Yahoo Finance Insights
·
November 09, 2020
Anish Tuladhar
·
October 30, 2020
Howard
·
October 29, 2020
mark
·
October 29, 2020
Rhys
·
October 27, 2020
CollegeBallParkFields
·
October 23, 2020
iConquerorYou
·
October 15, 2020
freedomrules
·
October 13, 2020
anonymous
·
October 09, 2020
Giovanni
·
October 07, 2020
stocktargetadvisor
·
September 21, 2020